Chemotherapy and Radiation
687 articles
Two New Immunotherapy Trials Aim to Make Therapy More Effective
Two clinical trials in the Lustgarten Foundation’s Clinical Accelerator are testing different combinations of immunotherapy.
A Clinical Trial Matches My Genetics
Steven Merlin learned that he carried the BRCA2 mutation after he developed pancreatic cancer. He researched and found a clinical trial for BRCA carriers.
The Key Role of an Oncology Dietitian in Pancreatic Cancer Treatment
Not sure what to eat during treatment? Oncology dietitian Antonella Apicella explains how to tailor an eating plan to your needs.
The Association of Community Cancer Centers (ACCC) Fights for Equitable Cancer Care
The Association of Community Cancer Centers helps local oncologists access the latest treatment and care information, says Dr. Leigh Boehmer.
For Families at Risk, Remote Education May Be Key in Improving Genetic Testing Uptake
What’s the best way to educate families at risk for pancreatic cancer about genetic testing? Dr. Sapna Syngal discusses the results of the GENERATE study.
Surveillance Improves Outcomes for High-Risk Patients
Dr. Michael Goggins provides results for the CAPS5 pancreatic cancer surveillance and screening study for patients at high risk.
Studying One Family’s Mutations May Change Pancreatic Cancer Treatment and Prevention
Dr. Sahar Nissim is studying the genetic mutations in one family predisposed to pancreatic cancer, to find new ways to combat the disease.
No Time to Wait: UK Pancreatic Cancer Patients Struggle with Treatment and Diagnostic Delays
Peter De Rosa of Pancreatic Cancer UK provides an update on how the COVID-19 pandemic has impacted pancreatic cancer patients in the UK.
Scanxiety—A Nearly Universal Experience Among Cancer Patients
Social worker Lauren Shaffer provides tips and insights into managing scanxiety, the worry that accompanies follow-up scans and tests for cancer patients.
Finding the Best Diabetes Drug for Pancreatic Cancer Patients
With all the various drugs out there, Dr. James Flory wants to establish which diabetes drug works best for pancreatic cancer patients. Read his expert advice.
Tumor Biology Matters
Dr. Lynn Matrisian of PanCAN, explains that molecular profiling of a pancreatic cancer patient’s tumor can show which treatment will work best.
Before You Leap: Genetic Testing for Pancreatic Cancer
Genetic counselor Megan Frone outlines the advantages of genetic testing when there is a family history of pancreatic cancer.
Cancer Commons: Bringing a Nurse Navigator to Cancer Patients
Nurse navigator Deborah Christensen helps Cancer Commons patients through the maze of clinical trials and treatment options.
New Clinical Accelerator Initiative Shortens Time from Bench to Clinic
Dr. Elizabeth Jaffee explains the importance of Lustgarten’s Clinical Accelerator Initiative to speed up the time from bench to trial.
The Positive Impact of a Pancreatic Cancer Clinical Trial
Richard Blish was a healthy, athletic 67-year-old when he developed symptoms of pancreatic cancer. His daughter steered him to a clinical trial for treatment.